Back to Search
ALBERTO BESSUDO, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1003888074IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A50309(CA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1989
Research & Publications (3)
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
PMID 18182663·J Clin Oncol·2008
3-trial
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.
PMID 17010047·Br J Haematol·2006
3-trial
Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses.
PMID 16754937·J Clin Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 326 SANTA FE DR STE 105
ENCINITAS, CA 92024 - Phone
- (760) 452-3340
Quick Facts
- NPI
- 1003888074
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 37
- Publications
- 3
Are you this provider?
Claim Your Profile